Alemtuzumab Interactions
There are 480 drugs known to interact with alemtuzumab, along with 3 disease interactions. Of the total drug interactions, 325 are major, and 155 are moderate.
- View all 480 medications that may interact with alemtuzumab
- View alemtuzumab disease interactions (3)
Most frequently checked interactions
View interaction reports for alemtuzumab and the medicines listed below.
- Acetaminophen-odan (acetaminophen)
- Acetylsalicylic Acid (aspirin)
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Alprazolam Intensol (alprazolam)
- Ambien (zolpidem)
- Ampyra (dalfampridine)
- Amrix (cyclobenzaprine)
- Andexxa (coagulation factor Xa)
- Aprodine (pseudoephedrine / triprolidine)
- Aspercreme Maximum Strength Lidocaine Patch (lidocaine topical)
- Aubagio (teriflunomide)
- Avonex (interferon beta-1a)
- Banzel (rufinamide)
- Betaseron (interferon beta-1b)
- Brilinta (ticagrelor)
- Briviact (brivaracetam)
- Carboplatin Novaplus (carboplatin)
- Celexa (citalopram)
- Clotrimazole Troche (clotrimazole)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Concerta (methylphenidate)
- Copaxone (glatiramer)
- Copper (copper gluconate)
- Iodides (sodium iodide)
- Tecfidera (dimethyl fumarate)
Alemtuzumab disease interactions
There are 3 disease interactions with alemtuzumab which include:
Report options
QR code containing a link to this page
More about alemtuzumab
- alemtuzumab consumer information
- Compare alternatives
- Reviews (21)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD52 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.